Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 4, 2024
[Advances in the Application of Adjuvant Chemotherapy and Targeted Therapy 
in Postoperative Patients with Stage I Lung Adenocarcinoma]Ke Zhao, Chao Guo, Yeye Chen, et al.
Critical Reviews in Oncology/Hematology|February 20, 2025
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysisYe Zhang, Yeye Chen, Chao Guo, et al.
Cell Death & Disease|November 21, 2025
HNRNPA2B1 confers immune escape of non-small cell lung cancer through targeting lactate/ferroptosisYe Zhang, Yeye Chen, Jiaqi Zhang, et al.
Carcinogenesis|August 13, 2025
BRINP3 promotes lung adenocarcinoma by enhancing CLOCK-mediated transcriptional regulation of CRYZL1 and activating the AKT pathwayYe Zhang, Cheng Huang, Yeye Chen, et al.
Biochemical Genetics|February 8, 2008
Relationships and hybridization among Smilax china and its affinities: evidence from allozyme dataAili Wang, Yeye Chen, Guangchun Chen, et al.
Orphanet Journal of Rare Diseases|June 6, 2022
Real-world clinicopathological features and outcome of thymic neuroendocrine tumors: a retrospective single-institution analysisYeye Chen, Jiaqi Zhang, Mengxin Zhou, et al.
World Journal of Surgical Oncology|June 3, 2014
Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis studyYaxin Liu, Cheng Huang, Hongsheng Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 18, 2015
[Primary Neuroendocrine Carcinoma of Thymus Caused Cushing Syndrome: Surgical Treatment and Prognosis Analysis]Li Li, Yeye Chen, Shanqing Li, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 28, 2022
[Application and Progress of Electromagnetic Navigation Bronchoscopy in Department of Thoracic Surgery]Chao Guo, Xiayao Diao, Cheng Huang, et al.
Oncology Reports|September 14, 2017
Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathwayZhijun Han, Xiaoyun Zhou, Shanqing Li, et al.
Pageof 6